{
    "title": "Biogen cuts profit forecast on higher deal costs (Nov 8)",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12725125/Biogen-cuts-annual-profit-forecast-higher-costs-persist.html",
    "date": "2023-11-08",
    "keywords": [
        "biogen",
        "year",
        "drug",
        "profit",
        "forecast",
        "treatment",
        "eisai",
        "end",
        "share",
        "revenue",
        "bhanvi",
        "satija",
        "mariam",
        "street",
        "company",
        "approval",
        "drugmaker",
        "tuesday",
        "march",
        "analyst",
        "sclerosis",
        "portfolio",
        "ceo",
        "viehbacher",
        "quarter",
        "acquisition",
        "partner",
        "target",
        "look",
        "therapy",
        "william",
        "blair",
        "way",
        "goal",
        "range",
        "growth",
        "driver",
        "face",
        "competition",
        "newer",
        "depression",
        "zurzuvae",
        "ataxia",
        "skyclarys",
        "purchase",
        "disease",
        "reata",
        "start",
        "transition",
        "maturing",
        "product",
        "christopher",
        "call",
        "focus",
        "anything",
        "significance",
        "mampa",
        "time",
        "helm",
        "sanofi",
        "aduhelm",
        "traction",
        "capital",
        "leqembi",
        "midsingle",
        "digit",
        "drop",
        "total",
        "thirdquarter",
        "spinraza",
        "atrophy",
        "contract",
        "reporting",
        "sunny",
        "bengaluru",
        "editing",
        "kalluvila",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}